Brief: Tiziana Life Sciences Regains Compliance With Nasdaq Listing Minimum Bid Price Rule
Aug 14 (Reuters) - Tiziana Life Sciences Ltd TLSA.O :
* TIZIANA LIFE SCIENCES REGAINS COMPLIANCE WITH NASDAQ
LISTING
MINIMUM BID PRICE RULE
Source text for Eikon: ID:nGNX5HM8NN
Further company coverage: TLSA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Tiziana Life Sciences
See all newsTiziana's experimental MS treatment meets main goals in mid-stage study
Brief: Tiziana Life Sciences - Submits Request To FDA For Orphan Drug Designation For Intranasal Foralumab For Msa
Brief: Tiziana Announces Last Patient Completes Last Visit In Phase 2A Inform-MS Trial Of Intranasal Foralumab
Brief: Tiziana Announces Last Patient Successfully Dosed In Its Phase 2 Inform-MS Trial
Brief: Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis